Generics - Ranbaxy Laboratories

Filter

Current filters:

Ranbaxy Laboratories

Popular Filters

26 to 41 of 41 results

Ranbaxy 1st-qtr 2013 earnings plunge 90% as sales fall 34%

08-05-2013

India's largest pharma company Ranbaxy Laboratories (BSE: 500359), which is majority owned by Japan's…

FinancialGenericsRanbaxy Laboratories

Daiichi Sankyo and Ranbaxy to launch branded generics in Brazil

21-04-2013

Japanese drug major Daiichi Sankyo (TYO: 4568) and its majority (64%)-owned Indian affiliate Ranbaxy…

Daiichi SankyoGenericsMarkets & MarketingPharmaceuticalRanbaxy LaboratoriesSouth America

Ranbaxy in deal with Alembic to market bioequivalent Pristiq in USA

05-03-2013

The US subsidiary of India's largest drugmaker, Ranbaxy Laboratories (AB: BO), which is majority owned…

Alembic PharmaceuticalsDaiichi SankyoGenericsLicensingMarkets & MarketingNeurologicalNorth AmericaPatentsPfizerPristiqRanbaxy Laboratories

India's Ranbaxy posts 23% sales growth for 2012

26-02-2013

India's largest drugmaker Ranbaxy Laboratories (AB: BO) yesterday reported financial results for 2012,…

FinancialGenericsRanbaxy Laboratories

Indian pharmaceuticals market led by Ranbaxy in terms of revenue

31-01-2013

The Indian pharmaceutical market is the world's third-largest in terms of volume and stands 14th in terms…

Asia-PacificBioconBiotechnologyGenericsMarkets & MarketingPanacea BiotecPharmaceuticalRanbaxy LaboratoriesSerum Institute of India

Daiichi Sankyo and Ranbaxy combine business operations in Thailand

16-01-2013

Japanese pharma major Daiichi Sankyo (TYO: 4568) and its 64%-owned affiliate Ranbaxy Laboratories (AB:…

Asia-PacificDaiichi SankyoGenericsManagementMarkets & MarketingPharmaceuticalRanbaxy Laboratories

Ranbaxy Labs' Absorica debuts in USA

27-11-2012

Indian drugmaker Ranbaxy Laboratories (AB: BO), which is majority owned by Japan's Daiichi Sankyo, said…

AbsoricaCipher PharmaceuticalsDaiichi SankyoDermatologicalsGalephar Pharmaceutival ResearchGenericsMarkets & MarketingNorth AmericaPharmaceuticalRanbaxy Laboratories

Ranbaxy Labs beats estimates, as 3rd-qtr sales leap 31%

09-11-2012

India's largest drugmaker Ranbaxy Laboratories (AB: BO) has reported financial results for the quarter…

FinancialGenericsRanbaxy Laboratories

Ranbaxy gains approval for new manufacturing plant in Malaysia

14-09-2012

India's largest drugmaker Ranbaxy Laboratories (AB: BO). said yesterday that the government of Malaysia…

Asia-PacificDaiichi SankyoGenericsProductionRanbaxy Laboratories

US FDA pulls 27 Ranbaxy ANDAs approvals under consent decree

23-08-2012

The Food and Drug Administration is withdrawing approval of 27 Abbreviated New Drug Applications (ANDAs)…

Antibiotics and Infectious diseasesDaiichi SankyoDiabetesGenericsNorth AmericaRanbaxy LaboratoriesRegulation

Daiichi Sankyo and Ranbaxy debut hybrid business model in Venezuela

20-06-2012

Japanese drug major Daiichi Sankyo (TYO: 4568) announced that its Daiichi Sankyo Venezuela unit would…

Daiichi SankyoGenericsMarkets & MarketingPharmaceuticalRanbaxy LaboratoriesSouth America

Ranbaxy sales rocket 55%, net rises four-fold

11-05-2012

Ranbaxy Laboratories (AB: BO), India's largest drugmaker, came in with a stompingly good set of financial…

Daiichi SankyoFinancialGenericsRanbaxy Laboratories

Daiichi Sankyo and Ranbaxy launch Sevikar in Romania

19-04-2012

Japanese drug major Daiichi Sankyo (TYO: 4568) and its majority-owned Indian subsidiary Ranbaxy Laboratories…

Cardio-vascularDaiichi SankyoEuropeGenericsMarkets & MarketingPharmaceuticalRanbaxy LaboratoriesSevikar

26 to 41 of 41 results

Back to top